Michael T. Nally
Executive vice president and chief marketing officer, Human Health
Michael Nally is the chief marketing officer for Merck, a leading research-intensive biopharmaceutical company with the mission to save and improve lives. Michael is leading the development of the company’s commercialization model of the future through leveraging data, advanced analytics and affordability solutions for our customers. In addition, he partners closely with research and manufacturing to create product development strategies, oversee marketing and strategy for the company’s human health organization.
Prior to this role, Michael served as president of global vaccines at Merck, which provides a broad and innovative portfolio of pediatric, adolescent and adult vaccines to the world. In this position, Michael and his team drove a dramatic increase in the reach and public health impact of vaccines while delivering significant business growth and establishing the leadership position in this area that the company enjoys today.
Additionally, Michael has led the company's business in Sweden and the United Kingdom, focusing on the development and implementation of innovative, customer-centered approaches that delivered improved business results and accelerated patient access to our medicines and vaccines. He has also held a variety of positions in commercial operations, business development and investor relations.
Michael holds an MBA from Harvard Business School, a degree in Accounting and Finance from the London School of Economics and a BA in Economics from Middlebury College.